Monthly dividend stocks promise 12 paychecks a year, but some of those checks quietly shrink while others quietly grow. Five popular names reveal just how different a monthly payout can look once coverage and…
Iran's latest threat against US energy assets in the Gulf sent oil past $91 a barrel, and the money is already rotating into a handful of names before most investors notice the trade is…
Ryan Cohen is sitting on a war chest worth billions, and what he chooses to do with it before Tuesday's close could matter far more to GameStop investors than any revenue line in the…
Medicare Part B premiums keep climbing, and Social Security checks keep shrinking to cover them. Three Dividend Kings with very different yields and coverage profiles could shift that math entirely in a retiree's favor.
AMD just announced a workstation that could pull sensitive AI workloads out of the cloud entirely, and the buyers it has in mind reveal exactly who stands to lose the most.
JEPI's monthly paycheck looks irresistible until you see exactly what the fund surrenders to produce it. Three Dividend Kings quietly sidestep that tradeoff, and the difference compounds in ways most income investors never stop…
Oracle's stock has cratered while Wall Street analysts stubbornly hold some of the most bullish price targets in the mega-cap space. With earnings dropping Thursday, something has to give.
Nvidia just paid nearly $13 billion to own the platform where the open-source AI community lives, works, and distributes its models. The question is whether that community will stay or walk.
Holding high-yield REITs and BDCs in a taxable brokerage triggers a recurring annual tax bill that quietly erodes returns for decades, and the account where you park these six tickers matters far more than…
Both stocks yield around 5% and both carry decades of dividend history, but the metrics that actually predict whether a payout survives a downturn tell two very different stories about which one deserves your…
A fat dividend yield can mean generosity or distress, and three well-known stocks paying some of the biggest yields in the market right now are showing cracks that most income investors are dangerously quick…
Treasury yields near a one-year high are punishing most dividend stocks, but a handful of Dividend Kings kept signing bigger checks every single quarter without missing a beat. The question is whether their balance…
Hyperscalers are signing multi-year leases at a pace that is rewriting the income playbook, and three REITs are quietly collecting the rent on every server warehouse in the deal. The question is which one…
Some dividend stocks raise their payouts through one recession, maybe two. A handful of consumer staples names have kept writing bigger checks through every downturn for decades, and the cash flow behind that streak…
Domino's has raised its dividend every year for over a decade and just approved another hefty increase, yet the balance sheet carries nearly $5 billion in debt and a stockholders' deficit that would alarm…
When tenants foot the bill for taxes, insurance, and maintenance, the landlord's job gets a lot simpler and the dividend check gets a lot more predictable. Three net lease REITs have quietly built some…
Gilead's quarterly dividend keeps growing and its HIV cash machine runs hot, but the whole enterprise depends on a single blockbuster drug with a patent expiration already penciled onto a calendar a decade out.…
High midstream yields look tempting until a payout cut wipes out a year of income, so the real question is not the yield itself but whether the cash flow behind it can actually survive…
AbbVie's flagship drug is bleeding revenue quarter after quarter, yet the company just handed shareholders another raise. Find out whether the cash machine holding this payout together can survive the patent reckoning already underway.
Pfizer shareholders are collecting a 6% yield while the stock bleeds value, and the CEO just made a bold promise about keeping that payout alive through what could be the company's toughest stretch in…
